F. Herth (Heidelberg, Germany), W. De Wever (Leuven, Belgium)
Value of MR imaging in the early detection of cardiac involvement in sarcoidosis
I. Lambiri, K. I. Pagonidis, M. Plataki, G. Maltezakis, T. G. Maris, A. Karantanas, N. Gourtsoyiannis, N. Siafakas (Heraklion, Greece)
|   |
Oxygen-enhanced MRI of the lung in the assessment of chronic obstructive pulmonary disease
M. Ciuffreda, G. M. Corbo, F. Molinari, T. Pirronti, L. Bonomo, S. Valente (Rome, Italy)
| |
Assessment of a new magnetic resonance imaging (MRI)-scoring- system for pulmonary changes in patients with cystic fibrosis (CF) – comparison with clinical parameters and high resolution computed tomography (HRCT)
J. Gahr, M. Eichinger, M. Puderbach, S. Ley, S. Tuengerthal, A. Schmaehl, J. Buschmann, M. Wiebel, S. Demirakca, C. Fink, C. Plathow, H. U. Kauczor, F. M. Mueller (Heidelberg, Mannheim, Germany)
| |
Free-breathing MDCT of the lung using prospective and retrospective respiratory gating in a large animal experiment
J. Zaporozhan, S. Ley, R. Unterhinninghofen, Y. Saito, M. Fabel-Schulte, G. Szabo, H. U. Kauczor (Heidelberg, Germany; Tochigi, Japan)
| |
Use of PET/CT to evaluate pulmonary inflammation and fibrosis in an animal model
A. Gazdhar, M. Hofmann, T. Krause, R. A. Schmid, T. Geiser (Bern, Switzerland)
| |
Regional distribution of inhaled particles measured with isotope scanning or modelled with computational fluid dynamics
J. De Backer, W. Vos, A. Devolder, S. Verhulst, L. Carp, P. Parizel, W. De Backer (Antwerp, Belgium)
| |
Lung vibration response imaging (VRI) – characteristics and variability of normal subjects
M. Yigla, I. Marom (Haifa, Israel)
| |
Clinical yield of vibration response imaging technology for pleural diseases
H. Dutau, K. Arlaud, L. Greillier, P. Astoul (Marseille, France)
| |